Latest News for: orexa

Edit

Orexa Announces First Patient Dosed in Phase 2 Trial in Post-Operative Patients

PR Newswire 08 Feb 2024
Study 2022-503113-31-00-IN-002 (EudraCT number) is a multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of Orexa's lead compound ORE-001 ... About Orexa.Orexa is developing a drug that increases food intake.
  • 1

Most Viewed

×